Last 12 months
Inside the activity.
0 purchase rows · 214 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 28 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 36 |
| Aug 2026 | 0 | 44 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 6 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2020 Filed Nov 20, 2020 21:38 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 709 | $46.51 | $32,978.43 |
DisclosureSEC source: 0001447362-20-000265 · wf-form4_160590826814695.xml · nonDerivative · entry 5 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 771,578 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $46.320 to $46.695, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 19, 2020 Filed Nov 20, 2020 21:38 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 3,041 | $45.90 | $139,581.90 |
DisclosureSEC source: 0001447362-20-000265 · wf-form4_160590826814695.xml · nonDerivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 772,287 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $45.320 to $46.295, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 18, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 801 | $48.23 | $38,628.23 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 7 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,361,946 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $48.020 to $48.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,755 | $47.54 | $130,980.97 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 6 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,747 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $46.960 to $47.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,694 | $46.37 | $124,926.17 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 5 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365,502 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $45.880 to $46.850, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:38 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 534 | $48.20 | $25,738.80 |
DisclosureSEC source: 0001447362-20-000265 · wf-form4_160590826814695.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 775,328 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $48.130 to $48.345, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:38 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 1,525 | $47.56 | $72,524.43 |
DisclosureSEC source: 0001447362-20-000265 · wf-form4_160590826814695.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 775,862 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $46.970 to $47.940, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:38 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 1,691 | $46.39 | $78,448.87 |
DisclosureSEC source: 0001447362-20-000265 · wf-form4_160590826814695.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 777,387 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $45.920 to $46.870, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 600 | $50.44 | $30,261.60 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368,196 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $50.010 to $50.990, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,200 | $49.17 | $59,005.20 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368,796 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $48.840 to $49.630, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 17, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 4,450 | $48.45 | $215,602.50 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,369,996 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $47.830 to $48.820, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 6,250 | $50.55 | $315,925.00 |
DisclosureSEC source: 0001447362-20-000263 · wf-form4_160574043533732.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,374,446 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $50.190 to $50.905, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 13,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · derivative · entry 11 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,137 Underlying: Common Stock · 13,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F8 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 200 | $52.04 | $10,408.00 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 9 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $52.010 to $52.070, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 633 | $51.30 | $32,474.17 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 8 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,086 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $51.000 to $51.800, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 12,167 | $50.41 | $613,301.97 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 7 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,719 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $50.000 to $50.885, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
Exercise / conversionCommon Stock | 13,000 | $2.39 | $31,070.00 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 6 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 13,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · derivative · entry 10 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,137 Underlying: Common Stock · 13,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F8 · derivative.exercise_date: The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 69 | $52.96 | $3,654.24 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 5 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,886 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 5,731 | $52.20 | $299,163.93 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 4 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,955 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $51.770 to $52.675, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 2,121 | $51.19 | $108,573.99 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 3 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,686 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $50.630 to $51.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
SaleCommon Stock | 5,079 | $50.20 | $254,970.88 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 2 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,807 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.585 to $50.560, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:14 UTC |
Stokes FrankChief Financial Officer
|
Exercise / conversionCommon Stock | 13,000 | $2.39 | $31,070.00 |
DisclosureSEC source: 0001447362-20-000261 · wf-form4_160556126671585.xml · nonDerivative · entry 1 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 12, 2020. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 545 | $50.99 | $27,790.64 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 8 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380,696 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F9 · price: This transaction was executed in multiple trades at prices ranging from $50.710 to $51.255, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 5,307 | $50.07 | $265,710.88 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 7 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,381,241 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F8 · price: This transaction was executed in multiple trades at prices ranging from $49.590 to $50.585, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,000 | $48.92 | $48,923.00 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 6 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386,548 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $48.555 to $49.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 200 | $46.36 | $9,272.00 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 5 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387,548 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $45.910 to $46.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 300 | $45.00 | $13,499.10 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387,748 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $44.630 to $45.480, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,000 | $50.34 | $50,341.00 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388,048 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.220 to $50.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,887 | $49.60 | $93,589.54 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,389,048 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $49.130 to $50.080, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:38 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,163 | $48.54 | $56,455.51 |
DisclosureSEC source: 0001447362-20-000259 · wf-form4_160521711400523.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390,935 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.100 to $49.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,049 | $52.18 | $106,925.02 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 6 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,392,098 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $51.765 to $52.570, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 4,201 | $51.51 | $216,389.31 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 5 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,147 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $50.760 to $51.735, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 21:07 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 100 | $52.56 | $5,256.00 |
DisclosureSEC source: 0001447362-20-000251 · wf-form4_160469678070295.xml · nonDerivative · entry 5 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 779,078 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 21:07 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 3,050 | $51.83 | $158,081.50 |
DisclosureSEC source: 0001447362-20-000251 · wf-form4_160469678070295.xml · nonDerivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 779,178 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $51.53 to $52.51, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 21:07 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 600 | $51.03 | $30,618.00 |
DisclosureSEC source: 0001447362-20-000251 · wf-form4_160469678070295.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 782,228 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $50.53 to $51.46, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,450 | $50.20 | $122,992.45 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,398,348 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $49.700 to $50.610, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 3,800 | $49.29 | $187,313.40 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,798 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $48.640 to $49.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:07 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 1,450 | $50.23 | $72,833.50 |
DisclosureSEC source: 0001447362-20-000251 · wf-form4_160469678070295.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 782,828 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $49.81 to $50.61, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:07 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,300 | $49.32 | $113,436.00 |
DisclosureSEC source: 0001447362-20-000251 · wf-form4_160469678070295.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 784,278 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $48.77 to $49.70, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 4,150 | $47.81 | $198,390.75 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,404,598 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $47.515 to $48.150, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:00 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,100 | $46.96 | $98,611.80 |
DisclosureSEC source: 0001447362-20-000249 · wf-form4_160461724172055.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,408,748 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $46.490 to $47.440, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:13 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 237 | $48.56 | $11,508.25 |
DisclosureSEC source: 0001447362-20-000247 · wf-form4_160408882247354.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,410,848 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $48.250 to $48.710, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:13 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 863 | $47.67 | $41,134.90 |
DisclosureSEC source: 0001447362-20-000247 · wf-form4_160408882247354.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,411,085 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $47.155 to $48.130, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 20:13 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 300 | $50.04 | $15,012.90 |
DisclosureSEC source: 0001447362-20-000247 · wf-form4_160408882247354.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,411,948 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $50.010 to $50.110, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 20:13 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 900 | $49.38 | $44,439.30 |
DisclosureSEC source: 0001447362-20-000247 · wf-form4_160408882247354.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412,248 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.010 to $49.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 20:06 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,000 | $48.87 | $48,869.00 |
DisclosureSEC source: 0001447362-20-000245 · wf-form4_160339714746734.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,148 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $48.400 to $49.085, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 20:06 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 200 | $47.34 | $9,467.00 |
DisclosureSEC source: 0001447362-20-000245 · wf-form4_160339714746734.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414,148 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $47.040 to $47.610, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 20:03 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 4,660 | $48.86 | $227,687.60 |
DisclosureSEC source: 0001447362-20-000243 · wf-form4_160339697345220.xml · nonDerivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 786,578 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on March 13, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $48.23 to $49.18, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 20:03 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 590 | $47.39 | $27,960.10 |
DisclosureSEC source: 0001447362-20-000243 · wf-form4_160339697345220.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 791,238 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on March 13, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $47.05 to $47.72, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.